Tumor thrombus of inferior vena cava in patients with renal cell carcinoma – clinical and oncological outcome of 50 patients after surgery

BMC Research Notes

Volumn 5, Issue 1, 2012, Pages

  Vergho, Daniel Claudius ^a   Loeser, Andreas ^a   Kocot, Arkadius ^a   Spahn, Martin ^a   Riedmiller, Hubertus ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Inferior vena cava; Renal cell carcinoma; Thrombectomy; Tumor thrombus

Indexed keywords

AGED; ARTICLE; FEMALE; HUMAN; INFERIOR CAVA VEIN; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MIDDLE AGED; PATHOLOGY; THROMBOSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; THROMBOSIS; TREATMENT OUTCOME; VENA CAVA, INFERIOR;

MLCS; MLOWN;

EID: 84872682982     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-264     Document Type: Article

References (31)

1. Kirkali Z, Van Poppel H: A critical analysis of surgery for kidney cancer with vena cava invasion. Eur Urol 2007, 52(3):658–662.
2. Kaag MG, Toyen C, Russo P, Cronin A, Thompson RH, Schiff J, Bernstein M, Bains M: Radical nephrectomy with vena caval thrombectomy: a contemporary experience. BJU Int 2011, 107(9):1386–1393.
3. Haferkamp A, Bastian PJ, Jakobi H, Pritsch M, Pfitzenmaier J, Albers P, Hallscheidt P, Mueller S, Hohenfellner M: Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup. J Urol 2007, 177(5):1703–1708.
4. Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, Gitlitz BJ, DeKernion JB, Figlin RA, Belldegrun AS: Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol 2003, 169(3):909–916.
5. Ciancio G, Livingstone AS, Soloway M: Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques. Eur Urol 2007, 51(4):988–994.
6. Staehler G, Brkovic D: The role of radical surgery for renal cell carcinoma with extension into the vena cava. J Urol 2000, 163(6):1671–1675.
7. Tanaka M, Fujimoto K, Okajima E, Tanaka N, Yoshida K, Hirao Y: Prognostic factors of renal cell carcinoma with extension into inferior vena cava. Int J Urol 2008, 15(5):394–398.
8. Choueiri TK, Xie W, Kollmannsberger C, North S, Knox JJ, Lampard JG, McDermott DF, Rini BI, Heng DY: The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy. J Urol 2011, 185(1):60–66.
9. You D, Jeong IG, Ahn JH, Lee DH, Lee JL, Hong JH, Ahn H, Kim CS: The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy. J Urol 2011, 185(1):54–59.
10. Leibovich BC, Cheville JC, Lohse CM, Zincke H, Kwon ED, Frank I, Thompson RH, Blute ML: Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? J Urol 2005, 173(3):716–719.
11. Belis JA, Kandzari SJ: Five-year survival following excision of renal cell carcinoma extending into inferior vena cava. Urology 1990, 35(3):228–230.
12. Moinzadeh A, Libertino JA: Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? J Urol 2004, 171(2pt1):598–601.
13. Fuhrman SA, Lasky LC, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982, 6(7):655–663.
14. Neves RJ, Zincke H: Surgical treatment of renal cancer with vena cava extension. Br J Urol 1987, 59(5):390–395.
15. Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004, 240(2):205–213.
16. Ciancio G, Manoharan M, Katkoori D, De Los SR, Soloway MS: Longterm Survival in Patients Undergoing Radical Nephrectomy and Inferior Vena Cava Thrombectomy: Single-Center Experience. Eur Urol 2010, 57(4):667–671.
17. Libertino JA, Zinman L, Watkins E Jr: Long-term results of resection of renal cell cancer with extension into inferior vena cava. J Uro 1987, 137(1):21–24.
18. Swierzewski DJ, Swierzewski MJ, Libertino JA: Radical nephrectomy in patients with renal cell carcinoma with venous, vena caval, and atrial extension. Am J Surg 1994, 168(2):205–209.
19. Lambert EH, Pierorazio PM, Shabsigh A, Olsson CA, Benson MC, McKiernan JM: Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus. Urology 2007, 69(6):1054–1058.
20. Flanigan RC, Mickisch G, Sylvester R, Tangen C, Van Poppel H, Crawford ED: Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 2004, 171(3):1071–1076.
21. Mickisch GH, Garin A, Van Poppel H, De Prick L, Sylvester R: Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001, 358(9286):966–970.
22. Di Lorenzo G, Autorino R, Sternberg CN: Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era. Eur Urol 2009, 56(6):959–971.
23. Di Silverio F, Sciarra A, Parente U, Andrea A, Von Heland M, Panebianco V, Passariello R: Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy. Urol Int 2008, 80(4):451–453.
24. Wagner B, Patard JJ, Mejean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes J, Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valeri A, Meyer N, Jacqmin D, Lang H: Prognostic Value of Renal Vein and Inferior Vena Cava Involvement in Renal Cell Carcinoma. Eur Urol 2009, 55(2):452–459.
25. Martinez-Salamanca JI, Huang WC, Millan I, Bertini R, Bianco FJ, Carballido JA, Cianco G, Hernandez C, Herranz F, Haferkamp A, Hohenfellner M, Hu B, Koppie T, Martinez-Ballesteros C, Montorsi F, Palou J, Pontes JE, Russo P, Terrone C, Villavicencio H, Volpe A, Libertino JA: Prognostic Impact of the 2009 UICC/AJCC TNM Staging System for Renal Cell Carcinoma with Venous Extension. Eur Urol 2011, 59:120–127.
26. Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, Kabbinavar FF, Belldegrun AS: Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol 2007, 178(4pt1):1189–1195.
27. Ljungberg B, Stenling R, Osterdahl B, Farrelly E, Aberg T, Roos G: Vein invasion in renal cell carcinoma: impact on metastatic behavior and survival. J Urol 1995, 154(5):1681–1684.
28. Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincker H: The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int 2004, 94(1):33–41.
29. Novick AC, Kaye MC, Cosgrove DM, Angermeier K, Pontes JE, Montie JE, Streem SB, Klein E, Stewart R, Goormastic M: Experience with cardiopulmonary bypass and deep hypothermic circulatory arrest in the management of retroperitoneal tumors with large vena caval thrombi. Ann Surg 1990, 212(4):472–476.
30. Stewart JR, Carey JA, McDougal WS, Merrill WH, Koch MO, Bender HW: Cavoatrial tumor thrombectomy using cardiopulmonary bypass without circulatory arrest. Ann Thorac Surg 1991, 51(5):717–721.
31. Granberg CF, Boorjian SA, Schaff HV, Orszulak TA, Leibovich BC, Lohse CM, Cheville JC, Blute ML: Surgical Management, Complications, and Outcome of Radical Nephrectomy with Inferior Vena Cava Tumor Thrombectomy Facilitated by Vascular Bypass. Urology 2008, 73(1):148–152.